The Outlook for eR&D Strategies: Online solutions to declining productivity in pharmaceutical research and development

Executive Summary

With 45% of the overall R&D budget and at least half of the time-to-market consumed by clinical trials, pharmaceutical companies are focusing efforts on accelerating product development through efficiencies in the clinical trial process. The management report The Outlook for eR&D Strategies: Online solutions to declining productivity in pharmaceutical R&D, explores the benefits that pharmaceutical companies can gain from using online solutions to accelerate the R&D process. This report will show you how to maximize efficiencies in the clinical trials process through methods such as online clinical trial recruitment, electronic patient diaries and electronic data capture and management. Although the pharmaceutical industry has been relatively slow to exploit the advantages of web technology, its wider uptake is inevitable and will be substantially accelerated by the global harmonization of data/systems standards and consequent shift to integrated clinical data management. Utilizing online solutions could produce immediate cost and time savings within your R&D process, find out how in this new management report.